MPS Limited acquires Unbound Medicine

MPS Limited agreed to acquire Unbound Medicine. Reported deal value: $16.5M. Status: Completed. Sector: healthcare and medical information technology. Target headquarters context: Charlottesville, Virginia, United States.

This page summarizes publicly available information about the transaction as of 2026-02-04. Figures and status may change as filings and press coverage update.

Cyril Amarchand Mangaldas ( CAM ) is acting as principal counsel to MPS Limited , a public limited company listed on Indian stock exchange and its subsidiary, MPS North America LLC (the Purchaser ), in relation to the acquisition of 100% of the issued and outstanding capital stock of Unbound Medicine , Inc. pursuant to a stock purchase agreement executed among the Company, the Purchaser, William M